Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

August 2001

Volume 7, Issue 3

Pages 181–280

  1. Original Contributions

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy (pages 181–189)

      Dr. Marla C. Dubinsky, Philip V. Hassard, Dr. Ernest G. Seidman, Lori Y. Kam, Maria T. Abreu, Dr. Stephan R. Targan and Eric A. Vasiliauskas

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00001

  2. Editorials

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. 6-Thioguanine: A naked bullet? (or how pharmacogenomics can make old drugs brand new) (pages 190–191)

      Filip Baert and Dr. Paul Rutgeerts

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00002

  3. Original Contributions

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease (pages 192–201)

      Dr. William J. Sandborn, Edward V. Loftus Jr, Jean Frederic Colombel, Kenneth A. Fleming, Frank Seibold, Henry A. Homburger, Boualem Sendid, Roger W. Chapman, William J. Tremaine, Debra K. Kaul, Jeannie Wallace, William S. Harmsen, Alan R. Zinsmeister and Stephan R. Targan

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00003

    2. Glucocorticoid receptor mRNA in patients with ulcerative colitis: A study of responders and nonresponders to glucocorticosteroid therapy (pages 202–209)

      Dr. Lars Flood, Robert Löfberg, Pontus Stierna and Ann-Charlotte Wikström

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00004

    3. Epithelial expression of caveolin-2, but not caveolin-1, is enhanced in the inflamed mucosa of patients with ulcerative colitis (pages 210–214)

      Dr. Akira Andoh, Takao Saotome, Haruhisa Sato, Tomoyuki Tsujikawa, Yoshio Araki, Yoshihide Fujiyama and Tadao Bamba

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00005

    4. The expression of IL-12 p40 and its homologue, epstein-barr virus-induced gene 3, in inflammatory bowel disease (pages 215–220)

      Fumio Omata, Mark Birkenbach, Shohei Matsuzaki, Andreas D. Christ and Dr. Richard S. Blumberg

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00006

    5. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: Comparison of orally administered mesalamine and sulfasalazine (pages 221–225)

      Makoto Naganuma, Yasushi Iwao, Haruhiko Ogata, Nagamu Inoue, Shinsuke Funakoshi, Shojirou Yamamoto, Yuji Nakamura, Hiromasa Ishii and Dr. Toshifumi Hibi

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00007

    6. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease (pages 226–236)

      Dr. Ian Craig Lawrance, Lesley Maxwell and William Doe

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00008

    7. Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis (pages 237–242)

      Dr. Per G. Farup, Thomas A. Hinterleitner, Milan Lukáš, Xavier Hébuterne, Daniel Rachmilewitz, Massimo Campieri, Rémy Meier, Ralf Keller, Barrie Rathbone and Einar Oddsson

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00009

    8. Colonoscopic findings in intestinal Behçet's disease (pages 243–249)

      Chung Ryul Lee, Won Ho Kim, Yong Suk Cho, Myoung Hwan Kim, Dr. Jae Hak Kim, In Suh Park and Dongsik Bang

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00010

    9. Cause of death in patients with inflammatory bowel disease (pages 250–255)

      Claudia Cucino and Dr. Amnon Sonnenberg

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00011

  4. Case Reports

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. Granulomatous lung masses in an elderly patient with inactive Crohn's disease (pages 256–259)

      Pedro F. Lucero, William C. Frey, Richard T. Shaffer and Dr. Michael J. Morris

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00012

  5. Clinical Review

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. Epidemiology of inflammatory bowel disease in Asia (pages 260–270)

      Dr. Suk-Kyun Yang, Edward V. Loftus Jr. and Dr. William J. Sandborn

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00013

  6. Basic Science On the Cutting Edge

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
  7. Selected Summaries

    1. Top of page
    2. Original Contributions
    3. Editorials
    4. Original Contributions
    5. Case Reports
    6. Clinical Review
    7. Basic Science On the Cutting Edge
    8. Selected Summaries
    1. Can a dose a day keep the colitis at bay? (page 276)

      Sunanda Kane

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00015

    2. Chronic diarrhea: To scope or not to scope? (pages 276–277)

      Jean-Paul Achkar

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00016

    3. Heparin in the treatment of inflammatory bowel disease: Dare we take the risk? (pages 277–279)

      Steve Bensen

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00017

    4. Prevention of colon cancer with ursodiol in ulcerative colitis (pages 279–280)

      Hyun Sil Kim

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200108000-00018

SEARCH

SEARCH BY CITATION